Strength and weakness of phase I to IV trials, with an emphasis on translational aspects

por Lønning, Per Eystein
Publicado 2008

Tailored targeted therapy for all: a realistic and worthwhile objective?

por Lønning, Per Eystein
Publicado 2009

Are current development programs realising the full potential of new agents?

por Lønning, Per Eystein
Publicado 2010

BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?

por Lønning, Per Eystein, Knappskog, Stian
Publicado 2018

Session 6 introduction

por Robertson, John FR, Lønning, Per Eystein
Publicado 2010

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved

por Lønning, Per Eystein, Eikesdal, Hans Petter
Publicado 2013

epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data

por Nikolaienko, Oleksii, Lønning, Per Eystein, Knappskog, Stian
Publicado 2023

Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines

por Huun, Johanna, Lønning, Per Eystein, Knappskog, Stian
Publicado 2017

ramr: an R/Bioconductor package for detection of rare aberrantly methylated regions

por Nikolaienko, Oleksii, Lønning, Per Eystein, Knappskog, Stian
Publicado 2021

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers

por Bjørnslett, Merete, Knappskog, Stian, Lønning, Per Eystein, Dørum, Anne
Publicado 2012

Adjuvant treatment: the contribution of expression microarrays

por Lønning, Per Eystein, Chrisanthar, Ranjan, Staalesen, Vidar, Knappskog, Stian, Lillehaug, Johan
Publicado 2007

Alterations of the retinoblastoma gene in metastatic breast cancer

por Berge, Elisabet Ognedal, Knappskog, Stian, Lillehaug, Johan Richard, Lønning, Per Eystein
Publicado 2011

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer

por Flågeng, Marianne Hauglid, Knappskog, Stian, Gjerde, Jennifer, Lønning, Per Eystein, Mellgren, Gunnar
Publicado 2015

The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer

por Poduval, Deepak, Sichmanova, Zuzana, Straume, Anne Hege, Lønning, Per Eystein, Knappskog, Stian
Publicado 2020

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer

por Poduval, Deepak, Sichmanova, Zuzana, Straume, Anne Hege, Lønning, Per Eystein, Knappskog, Stian
Publicado 2021

Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue

por Flågeng, Marianne Hauglid, Knappskog, Stian, Haynes, Ben P., Lønning, Per Eystein, Mellgren, Gunnar
Publicado 2013

Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour

por Straume, Anne Hege, Løvås, Kristian, Miletic, Hrvoje, Gravdal, Karsten, Lønning, Per Eystein, Knappskog, Stian
Publicado 2012

MDM4 SNP34091 (rs4245739) and its effect on breast‐, colon‐, lung‐, and prostate cancer risk

por Gansmo, Liv B., Romundstad, Pål, Birkeland, Einar, Hveem, Kristian, Vatten, Lars, Knappskog, Stian, Lønning, Per Eystein
Publicado 2015

Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases

por Løes, Inger Marie, Immervoll, Heike, Sorbye, Halfdan, Angelsen, Jon‐Helge, Horn, Arild, Knappskog, Stian, Lønning, Per Eystein
Publicado 2016

High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function

por Yndestad, Synnøve, Austreid, Eilin, Knappskog, Stian, Chrisanthar, Ranjan, Lilleng, Peer Kåre, Lønning, Per Eystein, Eikesdal, Hans Petter
Publicado 2017